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INTRODUCTION
Kinesin proteins make up a large superfamily of molecular
motors, known as kinesin superfamily proteins (KIFs). The
first kinesin was characterized by Vale et al. in 1985 as a cyto-
solic, microtubule-stimulated ATPase responsible for the
directed, ATP-dependent-vesicle movement within squid
axons (1). At the time, two motors, kinesin and dynein, seemed
almost sufficient to explain directional motility events on polar
microtubule tracks in the cell. Nonetheless, shortly after, the
tip of the iceberg began to emerge with the identification of
proteins containing a common domain. This domain, called
the ‘‘motor domain’’, confers on these proteins the essential
property of moving on microtubules, using the energy derived
from ATP hydrolysis. Since then, the identification of new
proteins belonging to the kinesin superfamily of microtubule-
dependent motors has gone at such a pace that nowadays more
than 200 entries with motor domain sequences are deposited
in the database.
Until now, more than 45 KIFs have been reported in mouse
and human genomes, which have two major functions (2).
KIFs participate in the movement of cargoes to specific des-
tinations along cytoskeletal tracks of microtubules (3). Addi-
tionally, KIFs are also involved in the organization of chromo-
somal and mitotic spindle movements (4, 5). Structurally, KIFs
consist of two functional domains: a motor domain that rever-
sibly binds to the cytoskeleton; and the rest of the molecule,
often referred to as the tail that interacts with cargo directly
(2, 3). We still do not understand how a specific kinesin is
linked to its cargo to ensure its delivery to the appropriate
location. Recently, several kinesin binding proteins have been
identified by yeast two-hybrid, genetic studies, and biochem-
ical analyses, and their roles in the cargo transport are now
being elucidated. Many cell biological approaches have demon-
strated that binding proteins and the motor function impact
all dynamic aspects of the generation and maintenance of cell
polarity and cell motility. Here we discuss the functions of
KIFs, cargo binding proteins and kinesin motor-based human
diseases.
KINESIN STRUCTURE AND CLASSIFICATION
The original ‘conventional’ kinesin (alias KIF5/kinesin-I)
was shown to be a tetrameric protein composed of two heavy
chains (110-120 kDa) and two light chains (60-70 kDa). Elec-
tron microscopy, protease sensitivity and primary sequence
analysis showed that the kinesin heavy chain (KHC) is com-
posed of three domains: N-terminal head domain,  -helical
stalk domain and C-terminal tail domain (6, 7). The globular
N-terminal head domain (residues 1-325) contains the adeno-
sine triphosphate (ATP)-binding motif and a microtubule-
binding domain. It is attached via 50 amino acid neck regions
to an extended  -helical stalk (residues 375-800), which forms
a coiled-coil upon dimerization with a second heavy chain.
The C-terminal tail domain (residues 800-963) is globular
and interacts with the kinesin light chains (KLC) (4). Outside
the motor domain, KIFs show few similarities to each other.
Recently, it has been clearly shown that several KIFs attach
to specific cargoes through interactions with adaptor proteins
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Intracellular organelle transport is essential for morphogenesis and functioning of
the cell. Kinesins and kinesin-related proteins make up a large superfamily of molec-
ular motors that transport cargoes such as vesicles, organelles (e.g. mitochondria,
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virus particles), and mRNAs in a microtubule- and ATP-dependent manner in neu-
ronal and non-neuronal cells. Until now, more than 45 kinesin superfamily proteins
(KIFs) have been identified in the mouse and human genomes. Elucidating the trans-
port pathways mediated by kinesins, the identities of the cargoes moved, and the
nature of the proteins that link kinesin motors to cargoes are areas of intense inves-
tigation. This review focuses on the structure, the binding partners of kinesins and
kinesin-based human diseases.
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in the C-terminal tail region. Since the characterization of the
first kinesin, many related proteins have been discovered,
including conventional kinesins as well as proteins belong-
ing to the growing kinesin superfamily proteins. A database
search of the total human genome indicated that there are a
total of 45 KIFs (2).
Three major types of KIFs have been identified according
to the position of the motor domain: NH2-terminal motor
domain type (N-type), middle motor domain type (M-type),
and COOH-terminal motor domain type (C-type) (2, 3). N-
type kinesins (KIF1, KIF3, KIF4, KIF5, KIF10, KIF12, KIF
13, KIF14, KIF15, KIF16, KIF17, KIF18, KIF20, KIF23,
KIF26) and M-type kinesin (KIF2) move exclusively towards
the plus-ends of microtubules like the cell periphery or synapse
terminal, whereas C-type kinesins (KIFC1, KIFC2, KIFC3)
move towards the minus-end (retrograde, or toward the nucle-
us, to a microtubule-organizing center, MTOC). Rotary shad-
owing and biochemical analysis shows that there are five types
of conformation for kinesin superfamily protein: homo-, and
heterodimers, heterotrimers (KIF3 containing two distinct
heavy chains, KIF3A and KIF3B, and one light chain, KAP3),
heterotetrameric (KIF5) and monomers (KIF1) (3).
CYTOPLASMIC KINESIN PROTEIN AND ITS
INTERACTION
Although the interaction of motors and cargoes are only
poorly understood, this is an area of rapid progress (8). Schli-
wa’s group searched for functional KHC domains using KHC
deletion mutant cDNAs expressed as transgenes and evaluated
their ability to rescue the deduced growth rate of a KHC-defi-
cient strain of Neurospora. In Neurospora, the tail coiled-coil
domain (820-918 amino acids) of KHC is essential for target-
ing and secretion to small vesicles at the hyphal tip (9). Hiro-
kawa’s group showed that an AMPA ( -amino-3-hydroxy-5-
methylisoxazole-4-propionate) receptor subunit-glutamate-
receptor-interacting protein (GRIP1), one of the multi-PDZ-
domain proteins at the synapse junction (10, 11), can directly
interact with this tail coiled-coil domain of KHC and steer
to dendrites as a motor for AMPA receptor (12) (Fig. 2A).
The region between the sixth and seventh PDZ domain of
GRIP1 binds to a region of KHC that overlaps the tail coiled-
coil domain defined in Neurospora. This interaction was further
confirmed by the observation that KHC and GRIP1 are pre-
sent on the same vesicles within the dendrites of cultured hip-
pocampus neurons and co-immunoprecitate in the vesicle frac-
tions. In addition, both gene targeting and dominant nega-
tive experiments of KHC resulted in abnormal localization
of GRIP1 and GluR2. In GRIP1 expressing neuronal cells,
KIF5 carries GRIP1 associated vesicles towards dendrites; on
the other hand, in cells expressing JSAP1/JIP3, KIF5 trans-
ports JSAP1 associated vesicles towards axons (12, 13). A sim-
ple explanation of this phenomenon is that binding proteins
determine the general direction of the traffic and also that KIF
family members can recognize multiple binding proteins or
cargoes.
A newly identified kinesin-like protein, KIF17, interacts
with the PDZ domain of sorting protein mLin-10 (Mint1/
X11), which is a component of a large complex that includes
mLin-2 (CASK), mLin-7 (Velis) and the transmembrane pro-
tein NR2B, a subunit of the N-methyl-D-aspartate (NMDA)
receptor (14). In the experiments of Hirokawa’s group, immu-
noprecipitation of KIF17 brought down the LIN complex as
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Fig. 1. Movement of kinesin along a microtubule. At the start of the
cycle, the ATP bounded head binds to the microtubule. ATP hydrol-
ysis in the first head and exchange of ATP for ADP in the second
head pulls the first head off the microtubule and moves the first
head along the microtubule. With the cycle repeats, kinesin has
moves the plus end of the microtubule.
Motor Scaffold proteins Cargo Disease Ref
KIF1A Liprin- AMPA receptor ? 55
KIF1B PSD-95/SAP-90/SAP-97/S-SCAM ? ? 56
KIF1B ? Synaptic vesicle Charcot-Marie-Tooth-2A 22
KIF1C 14-3-3 ? ? 57
KIF3 KAP3 Fodrin-associating vesicles Left-right body axis determination/
Kartageners triad/ Polycystic Kidney disease 18, 32
KIF5 GRIP AMPA receptor ? 12
KIF5 JIPs APP Alzheimer’s disease 47
KIF5 ? GLUT4 Diabetes (?) 54
KIF13A AP-1 complex Mannose-6-phosphate receptor ? 20
KIF17 mLin complex NMDA receptor ? 14
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well as the NMDA-receptor. In vitro vesicle motility exper-
iments and dominant inhibitory KIF17 constructs inhibit
nucleotide-dependent microtubule binding of NR2B-contain-
ing vesicles isolated from the brain and KIF17 promotes the
motility of isolated NR2B-containing vesicles along micro-
tubules (Fig. 2B). Also, cellular knockdown or functional
blockage of KIF17 expression using antisense oligonucleotides
decrease NR2B and mLin10 expression. Moreover, increase
in the expression level of NR2B by exposure to the NMDAR
antagonist increases the expression level of KIF17 (15).
Another KIF family member, KIF3 is one of the most abun-
dantly and ubiquitously expressed KIFs and predominantly
found in the nervous system (16). It is composed of a hetero-
trimeric complex formed with KIF3A, either KIF3B or KIF
3C, and an associated protein, KAP3 (17). In a yeast two-
hybrid binding assay, it was revealed that the KIF3 motor
and non-erythroid spectrin, termed fodrin, directly interacts
through the non-motor subunit of KIF3 and KAP3 (Fig. 2C).
Immunoprecipitation and immunoelectron microscopy fur-
ther confirmed the co-localization of fodrin and KIF3 on the
same vesicles, reinforcing the evidence that the cargo of the
KIF3 motor consists of fodrin-associating vesicles. In addition,
a pulse-labeling study has implied partial co-migration of
both molecules as fast flow components (18). 
Using affinity purification, velocity gradient, and direct in
vitro binding assays, another novel kinesin-like protein called
KIF13A was found to interact with the AP-1 clathrin-asso-
ciated adaptor complex, which helps mediate the transport
of coated vesicles from the trans-Golgi network (TGN) to the
plasma membrane (19). Also, using yeast two-hybrid, it was
verified that the C-terminal tail domain of KIF13A binds to
the  1-adaptin subunit of the AP-1 complex (20) (Fig. 2D).
Hirokawa’s group also showed that KIF13A, AP-1 and the
mannose-6-phosphate receptor (M6PR) are co-immunopre-
cipitated from cell lysates, and overexpression of the KIF13A
tail domain decreases the amount of M6PR at the plasma
membrane. These data demonstrate a link between the AP-1
complex and the cytoskeleton that allows KIF13A targeting
of vesicles containing M6PR from the TGN to the plasma
membrane.
As mentioned above, there are a total of 45 KIFs in the
human (2), which are responsible for many of the major micro-
tubule-dependent transport pathways in neuronal and non-
neuronal cells (21). At least several hundred different trans-
port complexes and membrane-bound organelles can travel
along microtubules. The diversity of these players, such as the
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Fig. 2. Schematic diagrams of the involvement of KIF5, KIF17, KIF3
and KIF13A in vesicle transport. (A) A model of the AMPA ( -amino-
3-hydroxy-5-methylisoxazole-4-propionate) receptor transporting
machinery. A subunit of AMPA receptor-GluR2-interacting protein
(GRIP1)-can directly interact with and steer KHCs to dendrites. (B)
A model of the NMDA receptor transporting machinery. Cargoes
containing NR2B are transported by KIF17, and the mLin-10 binding
domain is necessary for this function of KIF17. (C) A model of the
involvement of KIF3 in vesicle transport. The KIF3 complex conveys
fodrin-associated vesicles through a direct interaction with KAP3.
(D) A model of the involvement of KIF13A in vesicle transport. The
relationship between microtubule, KIF13A, and the AP-1 complex
is shown. The AP-1 complex links transmembrane receptors (in this
case M6PR) on the membrane to KIF13A through interaction be-
tween the AP-1 complex and the KIF13A tail domain.
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Fig. 3. The binding partners of KIFs. Biochemical observations
suggest that cargoes of motor proteins seem to be vesicles that
possess specific functional marker molecules. The KIF3 complex
conveys fodrin-associated vesicles through direct interaction of
KAP3 with fodrin and plays a role in neurite elongation. KIF5 trans-
ports APP containing vesicles in the axon and conveys AMPA re-
ceptor containing vesicles in the dendrite. KIF5 is committed to
carrying multiple cargoes to the axon or dendrite. KIF13A transports
M6PR containing vesicles through direct interaction with the AP-1
complex from the TGN to the plasma membrane. KIF17 conveys
NR2B-containing vesicles via a complex of mLin-10, mLin-2 and
mLin-7, and may modulate the efficacy of synaptic transmission.
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motor protein, a cargo-bound receptor, and accessory compo-
nents may explain how a limited number of kinesins do their
work for the wide variety of cellular transport tasks. Despite
the current knowledge of kinesin binding proteins detailed
above, there are no known receptors (adaptor proteins) for
cargoes such as synaptic vesicles, mitochondria, lysosomes
and mRNA complexes, which are also dependent on kinesin
transport. 
HOW COULD MOTORS BE INVOLVED IN HUMAN
DISEASES?
CMT and neurodegenerative diseases
Through the study of molecular motors, axonal transport
has been proven to be involved in Charcot-Marie-Tooth dis-
ease (CMT) 2A pathogenesis (22). CMT is classified into type
I and type II by using motor nerve conduction velocity as a
marker of myelin degeneration (23, 24). KIF1B is an isoform
of the conventional mitochondrial motor KIF1B. It is wide-
ly distributed both in the cell bodies and axons of neurons,
and its tail domain has a 61% amino acid homology to that
of KIF1A (25). CMT2A, an autosomal dominant subtype of
type II CMT, was mapped to human chromosome 1p35-36.
The human KIF1B locus is closely linked to the CMT2A locus
(22). Hirokawa’s group analyzed the KIF1B locus in CMT2A
patients and discovered a Q98L missense mutation in the ATP
binding consensus sequence of the motor domain. KIF1B
knockout mice die at birth from apnea due to nervous system
defects. KIF1B heterozygotes have a defect in synaptic vesicle
precursor transport and suffer from progressive muscle weak-
ness with a motor nerve conduction velocity within the nor-
mal range, resembling the symptoms of CMT2. A cell biolog-
ical approach demonstrated that KIF1B co-fractionates with
membranous organelles containing synaptic vesicle protein
and is co-localized with synaptic vesicle protein on vesicle
membranes. GST-pull down and immunoprecipitation assays
with a membrane vesicle fraction of mouse brain also showed
that KIF1B is associated with vesicles containing synaptic
vesicle proteins such as synaptotagmins, synaptophysin and
SV2. Accordingly, in CMT2A patients and kif1B+/- mice, haplo-
insufficiency of the KIF1B motor results in a deficiency of
the cargo proteins being transported by this motor, including
synaptic vesicle proteins in nerve axons and endings, brings
about progressive dysfunction of peripheral neurons (22).
KIF1A, a murine homologue of Unc-104 in Caenorhabditis
elegans, is a unique monomeric neuron-specific microtubule
plus end-directed motor (26). KIF1A mediates the transport
of a synaptic vesicle precursor and is essential for the viability,
maintenance and function of neurons, particularly of mature
neurons (27). In some neurodegenerative diseases, such as senile
dementia, neuronal cell death caused by defects in the trans-
port of synaptic vesicle precursors by KIF1A may be involved.
Polycystic kidney disease and Kartagener’s syndrome
Polycystic kidney disease is a common genetic disorder that
is characterized by the accumulation of fluid-filled cysts in
the kidney, liver and other organs (28, 29). Several proteins
that are encoded by genes associated with polycystic kidney
disease have been identified in primary cilia. Also, recent obser-
vations suggest that abnormalities of primary cilia play a role
in the cyst formation. Primary cilia are hair-like organelles that
consist of an axoneme containing nine peripheral pairs of
microtubules surrounded by a ciliary membrane (30). The
synthesis of primary cilia involves a process known as intraflag-
ellar transport, in which large particles containing protein
cargo are transported along the ciliary axoneme (31). The
anterograde movement of proteins along the axoneme is medi-
ated by KIF3. In experiments by Hirokawa’s and Goldstein’s
groups, mutations in the gene encoding the KIF3A or KIF3B
subunits in mice cause an embryonic lethal phenotype (32-34).
The nodal cilia, in which the heterotrimeric motor KIF3 is
localized, rotate to generate a unidirectional flow of extra-em-
bryonic fluid (nodal flow), which could fundamentally control
left-right determination (32). In the null mutants of KIF3,
there are no nodal flows. Thus, KIF3 is essential for develop-
ment of the left-right axis determination due to its involve-
ment in intraciliary transport of materials for ciliogenesis of
motile primary cilia in the embryo (32). Kartagener’s syn-
drome, a combination of defects that appear as abnormalities
in nodal cilia, bronchial cilia and sperm flagella, is also caused
by malfunctioning of the KIF3-dependent intracellular trans-
port pathway. In anterograde transport pathways, KIF3 has
been found in many typical neurons that lack cilia (16, 17, 35-
37). In a specific subset of neurons in Drosophila, mutants
lacking a KIF3 display reduced transport of the soluble enzyme
choline acetyltransferase from cell bodies to the synapse (38).
Alzheimer’s disease
Alzheimer’s disease is primarily a neuronal disease. Previous
studies have identified the possible role of amyloid precursor
protein (APP) in the initiation or progression of Alzheimer’s
disease (39). APP is a transmembrane protein which in vivo
is subjected to proteolytic cleavage (40). This cleavage produces
the extracellular amyloid  -peptide of Alzheimer’s disease and
releases an intracellular tail fragment of unknown function.
APP is synthesized in the endoplasmic reticulum, glycosylated
in the Golgi apparatus, and then packaged into vesicular struc-
tures that are transported to the plasma membrane (41). Con-
ventional kinesin (KIF5) was first discovered in a squid fast
axoplasmic transport system, but its in vivo function and asso-
ciated cargo have been uncertain for many years (1, 42). KIF5
is a heterotetramer consisting of two KHCs and two KLCs
(43). KLCs consist of at least two structurally distinct regions:
an N-terminal region of heptad repeats and a C-terminal re-
gion that has six-tetratrico peptide repeats (TRP) (44). Previ-ous antisense experiments revealed that KIF5 was needed for
APP transport in neurons (45). Co-immunoprecipitation,
velocity gradient sedimentation and biochemical experiments
confirmed this interaction and revealed that the cytoplasmic
domain of APP binds directly to the TRP region of KLC (46,
47). In addition, analysis of KLC knockout mice revealed that
APP transport in sciatic nerve axons strongly depends on KLC,
showing dramatic reduction in its absence compared with
normal animals. Based on the tight binding of APP to KLC,
and the strong dependence of APP axonal transport on KLC,
it was proposed that KIF5 is associated with a defined class
of vesicular cargoes in the axon that contain APP and the
transmembrane proteins involved in its proteolytic cleavage
(47, 48). These findings suggest that axonal transport dys-
function or aberrant trafficking of APP might be an impor-
tant element in the pathogenesis of Alzheimer’s disease.
Diabetes
Glucose homeostasis in humans is dependent upon the cata-
lytic activity of a glucose transporter protein, GLUT4 that
responds to insulin by translocation from intracellular vesicles
to the plasma membrane (49-51). Ablation of GLUT4 expres-
sion in either adipocytes or skeletal muscle of mice can lead
to diabetes (52, 53). Insulin stimulates glucose uptake in mus-
cle and adipose cells by mobilizing intracellular membrane
vesicles containing GLUT4 glucose transporter protein to
the plasma membrane. In the experiments of Czech’s group,
KIF5B is highly expressed in adipocytes and co-localizes with
perinuclear GLUT4. Dominant-negative mutants of KLC
blocked outward GLUT4 vesicle movements and transloca-
tion to the plasma membrane in response to insulin (54). These
findings suggest that dysfunction of GLUT4 transport might
be an important element in the pathogenesis of diabetes.
CONCLUSIONS AND OUTLOOK
This year is the eighteenth anniversary of the discovery of
kinesin motor proteins, but the field has advanced far past the
‘puberty’ stage, and has reached a degree of maturity previously
unforeseen. Since the first characterization of kinesin in 1985,
many studies have revealed various members in this superfam-
ily of proteins with correspondingly diverse functions. How-
ever, the relationship between kinesin and disease still raises
a lot of intriguing questions. Understanding the interaction
of kinesin and cargoes will be crucial in unveiling the intri-
cacies of kinesin-related human disease and will further elu-
cidate the mechanism of their regulation.
ACKNOWLEDGMENT
We thank HJ Kim for her help in constructing and draw-
ing the Figures. This work was supported by the 2002 Inje
University research grant.
REFERENCES
1. Vale RD, Reese TS, Sheetz MP. Identification of a novel force-gen-
erating protein, kinesin, involved in microtubule-based motility. Cell
1985; 42: 39-50. 
2. Miki H, Setou M, Kaneshiro K, Hirokawa N. All kinesin superfamily
protein, KIF, genes in mouse and human. Proc Natl Acad Sci USA
2001; 98: 7004-11. 
3. Hirokawa N. Kinesin and dynein superfamily proteins and the mech-
anism of organelle transport. Science 1998; 279: 519-26. 
4. Vale RD, Fletterick RJ. The design plan of kinesin motors. Annu Rev
Cell Dev Biol 1997; 13: 745-77. 
5. Sharp DJ, Rogers GC, Scholey JM. Microtubule motors in mitosis.
Nature 2000; 407: 41-7. 
6. Bloom GS, Wagner MC, Pfister KK, Brady ST. Native structure and
physical properties of bovine brain kinesin and identification of the
ATP-binding subunit polypeptide. Biochemistry 1988; 27: 3409-16. 
7. Yang JT, Laymon RA, Goldstein LS. A three-domain structure of
kinesin heavy chain revealed by DNA sequence and microtubule
binding analyses. Cell 1989; 56: 879-89. 
8. Karcher RL, Deacon SW, Gelfand VI. Motor-cargo interactions: the
key to transport specificity. Trends Cell Biol 2002; 12: 21-7. 
9. Seiler S, Kirchner J, Horn C, Kallipolitou A, Woehlke G, Schliwa M.
Cargo binding and regulatory sites in the tail of fungal conventional
kinesin. Nat Cell Biol 2000; 2: 333-8. 
10. Dong H, O’Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL.
GRIP: a synaptic PDZ domain-containing protein that interacts with
AMPA receptors. Nature 1997; 386: 279-84. 
11. Srivastava S, Osten P, Vilim FS, Khatri L, Inman G, States B, Daly
C, DeSouza S, Abagyan R, Valtschanoff JG, Weinberg RJ, Ziff EB.
Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA
receptor-binding protein ABP. Neuron 1998; 21: 581-91. 
12. Setou M, Seog DH, Tanaka Y, Kanai Y, Takei Y, Kawagishi M, Hi-
rokawa N. Glutamate-receptor-interacting protein GRIP1 directly
steers kinesin to dendrites. Nature 2002; 417: 83-7.
13. Bowman AB, Kamal A, Ritchings BW, Philp AV, McGrail M, Gind-
hart JG, Goldstein LS. Kinesin-dependent axonal transport is medi-
ated by the sunday driver (SYD) protein. Cell 2000; 103: 583-94. 
14. Setou M, Nakagawa T, Seog DH, Hirokawa N. Kinesin superfamily
motor protein KIF17 and mLin-10 in NMDA receptor-containing
vesicle transport. Science 2000; 288: 1796-802. 
15. Guillaud L, Setou M, Hirokawa N. KIF17 dynamics and regulation
of NR2B trafficking in hippocampal neurons. J Neurosci 2003; 23:
131-40.
16. Kondo S, Sato-Yoshitake R, Noda Y, Aizawa H, Nakata T, Matsuura
Y, Hirokawa N. KIF3A is a new microtubule-based anterograde motor
in the nerve axon. J Cell Biol 1994; 125: 1095-107. 
17. Yamazaki H, Nakata T, Okada Y, Hirokawa N. KIF3A/B: a hetero-
dimeric kinesin superfamily protein that works as a microtubule plus
end-directed motor for membrane organelle transport. J Cell Biol
Structure, Cargo and Disease of the Kinesin Superfamily Proteins 51995; 130: 1387-99. 
18. Takeda S, Yamazaki H, Seog DH, Kanai Y, Terada S, Hirokawa N.
Kinesin superfamily protein 3 (KIF3) motor transports fodrin-asso-
ciating vesicles important for neurite building. J Cell Biol 2000 20;
148: 1255-65. 
19. Kirchhausen T. Clathrin adaptors really adapt. Cell 2002 17; 109:
413-6.
20. Nakagawa T, Setou M, Seog D, Ogasawara K, Dohmae N, Takio K,
Hirokawa N. A novel motor, KIF13A, transports mannose-6-phosphate
receptor to plasma membrane through direct interaction with AP-1
complex. Cell 2000; 103: 569-81.
21. Vale RD. The molecular motor toolbox for intracellular transport.
Cell 2003; 112: 467-80. 
22. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang
HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hi-
rokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation
in a microtubule motor KIF1B beta. Cell 2001; 105: 587-97. 
23. Harding AE, Thomas PK. Genetic aspects of hereditary motor and
sensory neuropathy (types I and II). J Med Genet 1980; 17: 329-36. 
24. Kim SW, Lee KS, Jin HS, Lee TM, Koo SK, Lee YJ, Jung SC. Rapid
detection of duplication/deletion of the PMP22 gene in patients with
Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with
liability to pressure palsy by real-time quantitative PCR using SYBR
Green I Dye. J Korean Med Sci 2003; 18: 727-32.
25. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Ya-
mazaki H, Hirokawa N. KIF1B, a novel microtubule plus end-directed
monomeric motor protein for transport of mitochondria. Cell 1994;
79: 1209-20. 
26. Okada Y, Yamazaki H, Sekine-Aizawa Y, Hirokawa N. The neuron-
specific kinesin superfamily protein KIF1A is a unique monomeric
motor for anterograde axonal transport of synaptic vesicle precursors.
Cell 1995; 81: 769-80. 
27. Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, Takei Y,
Terada S, Noda T, Hirokawa N. Defect in synaptic vesicle precursor
transport and neuronal cell death in KIF1A motor protein-deficient
mice. J Cell Biol 1998; 141: 431-41. 
28. Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney
disease. J Am Soc Nephrol 2002; 13: 2384-98.
29. Lin F, Hiesberger T, Cordes K, Sinclair AM, Goldstein LS, Somlo
S, Igarashi P. Kidney-specific inactivation of the KIF3A subunit of
kinesin-II inhibits renal ciliogenesis and produces polycystic kidney
disease. Proc Natl Acad Sci USA 2003; 100: 5286-91. 
30. Wheatley DN. Primary cilia in normal and pathological tissues. Patho-
biology 1995; 63: 222-38. 
31. Rosenbaum JL, Witman GB. Intraflagellar transport. Nat Rev Mol
Cell Biol 2002; 3: 813-25. 
32. Nonaka S, Tanaka Y, Okada Y, Takeda S, Harada A, Kanai Y, Kido
M, Hirokawa N. Randomization of left-right asymmetry due to loss
of nodal cilia generating leftward flow of extraembryonic fluid in mice
lacking KIF3B motor protein. Cell 1998; 95: 829-37.
33. Takeda S, Yonekawa Y, Tanaka Y, Okada Y, Nonaka S, Hirokawa
N. Left-right asymmetry and kinesin superfamily protein KIF3A: new
insights in determination of laterality and mesoderm induction by
kif3A-/- mice analysis. J Cell Biol 1999; 145: 825-36.
34. Marszalek JR, Ruiz-Lozano P, Roberts E, Chien KR, Goldstein LS.
Situs inversus and embryonic ciliary morphogenesis defects in mouse
mutants lacking the KIF3A subunit of kinesin-II. Proc Natl Acad Sci
USA 1999; 96: 5043-8. 
35. Muresan V, Abramson T, Lyass A, Winter D, Porro E, Hong F, Cham-
berlin NL, Schnapp BJ. KIF3C and KIF3A form a novel neuronal
heteromeric kinesin that associates with membrane vesicles. Mol Biol
Cell 1998; 9: 637-52. 
36. An CH, Choi JC, Lee BH, Park YB, Jee HS, Park SJ, Kim JY, Park
IW, Choi BW, Hue SH. One case of Kartagener’s syndrome with
extracemtral microtubule in cilia. Korean J Med 2000; 59: 230-4.
37. Yang Z, Goldstein LS. Characterization of the KIF3C neural kinesin-
like motor from mouse. Mol Biol Cell 1998; 9: 249-61. 
38. Ray K, Perez SE, Yang Z, Xu J, Ritchings BW, Steller H, Goldstein
LS. Kinesin-II is required for axonal transport of choline acetyltrans-
ferase in Drosophila. J Cell Biol 1999; 147: 507-18. 
39. Price DL, Sisodia SS. Mutant genes in familial Alzheimer’s disease
and transgenic models. Annu Rev Neurosci 1998; 21: 479-505. 
40. Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC,
Oltersdorf T. Beta-amyloid precursor protein of Alzheimer disease
occurs as 110- to 135-kilodalton membrane-associated proteins in
neural and nonneural tissues. Proc Natl Acad Sci USA 1988; 85:
7341-5. 
41. Selkoe DJ. The cell biology of beta-amyloid precursor protein and
presenilin in Alzheimer’s disease. Trends Cell Biol 1998; 8: 447-53. 
42. Schnapp BJ, Vale RD, Sheetz MP, Reese TS. Single microtubules
from squid axoplasm support bidirectional movement of organelles.
Cell 1985; 40: 455-62. 
43. Scholey JM, Heuser J, Yang JT, Goldstein LS. Identification of glob-
ular mechanochemical heads of kinesin. Nature 1989; 338: 355-7. 
44. Blatch GL, Lassle M. The tetratricopeptide repeat: a structural motif
mediating protein-protein interactions. Bioessays 1999; 21: 932-9. 
45. Ferreira A, Niclas J, Vale RD, Banker G, Kosik KS. Suppression of
kinesin expression in cultured hippocampal neurons using antisense
oligonucleotides. J Cell Biol 1992; 117: 595-606. 
46. Gunawardena S, Goldstein LS. Disruption of axonal transport and
neuronal viability by amyloid precursor protein mutations in Drosophi-
la. Neuron 2001; 32: 389-401. 
47. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein
LS. Kinesin-mediated axonal transport of a membrane compartment
containing beta-secretase and presenilin-1 requires APP. Nature
2001; 414: 643-8. 
48. Kamal A, Goldstein LS. Connecting vesicle transport to the cytoskele-
ton. Curr Opin Cell Biol 2000; 12: 503-8. 
49. Olson AL, Pessin JE. Structure, function, and regulation of the mam-
malian facilitative glucose transporter gene family. Annu Rev Nutr
1996; 16: 235-56. 
50. Czech MP, Corvera S. Signaling mechanisms that regulate glucose
transport. J Biol Chem 1999; 274: 1865-8. 
51. Bryant NJ, Govers R, James DE. Regulated transport of the glucose
transporter GLUT4. Nat Rev Mol Cell Biol 2002; 3: 267-77. 
52. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann
T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4
gene impairs insulin action in muscle and liver. Nature 2001; 409:
6 D.-H. Seog, D.-H. Lee, S.-K. Lee 729-33.
53. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F,
Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear
LJ, Kahn CR, Kahn BB. Targeted disruption of the glucose transporter
4 selectively in muscle causes insulin resistance and glucose intoler-
ance. Nat Med 2000; 6: 924-8. 
54. Semiz S, Park JG, Nicoloro SM, Furcinitti P, Zhang C, Chawla A,
Leszyk J, Czech MP. Conventional kinesin KIF5B mediates insulin-
stimulated GLUT4 movements on microtubules. EMBO J 2003; 22:
2387-99. 
55. Shin H, Wyszynski M, Huh KH, Valtschanoff JG, Lee JR, Ko J, Streuli
M, Weinberg RJ, Sheng M, Kim E. Association of the kinesin motor
KIF1A with the multimodular protein liprin-alpha. J Biol Chem 2003;
278: 11393-401. 
56. Mok H, Shin H, Kim S, Lee JR, Yoon J, Kim E. Association of the
kinesin superfamily motor protein KIF1Balpha with postsynaptic
density-95 (PSD-95), synapse-associated protein-97, and synaptic
scaffolding molecule PSD-95/discs large/zona occludens-1 proteins.
J Neurosci 2002; 22: 5253-8. 
57. Dorner C, Ullrich A, Haring HU, Lammers R. The kinesin-like motor
protein KIF1C occurs in intact cells as a dimer and associates with
proteins of the 14-3-3 family. J Biol Chem 1999; 274: 33654-60. 
Structure, Cargo and Disease of the Kinesin Superfamily Proteins 7